Abstract
Non-enzymatic reactions have held relatively little appeal for biomedical researchers who work with mammalian tissues and eucharyotic cells, and understandably so. When confronted with the splendid array and catalytic efficiencies of enzymes, it can be argued that “uncatalyzed” reactions should be rare in occurrence and probably minor in significance. Accumulated studies indicate however, that presumably non-enzymatic reactions — in particular, bimolecular condensations between amino compounds and aldehydes or α-keto acids — are not as uncommon as assumed. In part, this revelation is due to the new and highly sensitive chromatography methods which have developed recently (Collins, 1977). And other studies, neuropharmacological, enzymological, and behavioral in nature, demonstrate that certain condensation “products” are clearly not insignificant or innocuous agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
ALPERS, H.S., MCLAUGHLIN, B., NIX, W.M., AND DAVIS, V.E., 1975, Inhibition of catecholamine uptake and retention in synaptosomal preparations by tetrahydroisoquinoline and tetrahydroprotoberberine alkaloids. Biochem. Pharmacol., 24, 1391–1396.
BENESCH, R.E., YUNG, S., SUZUKI, T., BAUER, C., and BENESCH, R., 1973, Pyridoxal compounds as specific reagents for the α and β N-termini of hemoglobin. Proc, Nat. Acad. Sci, USA, 70, 2595–2599.
BIGDELI, M. and COLLINS, M.A., 1975, Tissue catecholamines and potential tetrahydroisoqulnoline alkaloid metabolites: A gas chromatographic assay method with electron capture detection. Biochem. Med., 12, 55–65.
BROSSI, A., FOCELLA, A, and TEXTEL, S., 1972, Condensation of L-DOPA and its two mono-methyl ethers with formaldehyde and acetalde- hyde. Helv. Chim. Acta, 55, 15–21.
CASHAW, J.L., MCMURTREY, K., BROWN, H, and DAVIS, V.E., 1974, Identification of catecholamine-derived alkaloids in mammals by gas chromatography and mass spectrometry. J. Chromatog., 99, 567–573.
COHEN, G., 1976, Alkaloid products in the metabolism of alcohol and biogenic amines. Biochem. Pharmacol., 25, 1123–1128.
COHEN, G, and COLLINS, M.A., 1970, Alkaloids from catecholamines in adrenal tissue: Possible role in alcoholism, Science, 167, 1749–1751.
COLLINS, M.A., 1977, Identification of isoquinoline alkaloids during alcohol intoxication, in Alcohol and Opiates: Neurochem. Behav. Mech. (Ed. K. Blum), Acad. Press, N.Y., 155–166.
COSCIA, C.J., BURKE, W., JAMROZ, G., LASALA, J., MCFARLANE, J., MITCHELL, J., OTOOLE, M., and WILSON, M., 1977, Occurrence of a new class of tetrahydroisoqulnoline alkaloids in L-DOPA- treated parkinsonian patients. Nature, 269, 617–619.
DOUGAN, D., WADE, D., and MEARRICK, P., 1975, Effects of L-DOPA metabolites at a dopamine receptor suggest a basis for ’on-off effects in Parkinson’s disease. Nature, 254, 70–72.
DILLON, J., SPECTOR, A., and NAKANISHI, K., 1976, Identification of beta-carbolines isolated from fluorescent human lens protein. Nature, 259, 422–423.
FARRELL, G. and MCISAAC, W.M., 1961, Adrenoglomerulotropin. Arch. Biochem. Biophys., 94, 543–544.
FLÜCKIGER, R. and WINTERHALTER, K.H., 1976, In vitro synthesis of hemoglobin Ai, FEBS Letts., 71, 356–360.
GALLAGHER, B., 1971, The influence of tyrosine, phenylpyruvate and vitamin Bfupon Scizure thresholds, J. Neurochem., 18, 799–808.
GALLOWAY, M.P. BURKE, W.J., KOSLOFF, A., LIEBERMAN, D.L., MITCHELL, J., and COSCIA, C.J., 1978, Effect of a class of naturally-occurring tetrahydroisoquinolines on catecholamine metabolism in rat adrenal medulla; Importance of methylation. Neurosci. Abst. 4, 315.
GRAF, R.J., HALTER, J.B., and PORTE, D., 1978, Glycosylated hemoglobin in normal and diabetic subjects. Diabetes, 27, 834–839.
HANEY, and BUM, H.F., 1976, Glycosylation of haemoglobin in vitro: affinity labeling of hemoglobin by glucose -6- phosphate, Proc. Nat, Acad. Sci. USA, 73, 3534–3538.
HSIA, Y.E., 1976, Disorders of amino acid metabolism, in Basic Neurochemistry (Eds. Siegel, G., Albers, R.W., Ratzman, R, and Agranoff, B.), Little, Brown and Co., 2nd Ed., 500–541.
KAMETANI, T., TAKEMURA, M., XHARA, M., TAKAHASHI, K., and FUKUMOTO, K., 1976, Biotransformation of 1-benzyl-l,2,3,4- tetrahydro-2-methyl-isoquinolines into tetrahydroprotoberberlnes with rat liver enzymes. J, Amer. Chem. Soc, 98, 1956–1959
KOENIG, R., PETERSON, C.M., JONES, R.L., SAUDEK, C., LEHRHAN, M., and CERAMI, A., 1976, Correlation of glucose regulation and hemoglobin Aic in diabetes mellitus, N. Engl. J. Med., 295, 417–420.
LASAX, A.J.M., COSCIA, C.J. and CICERO, T.J., 1978, Inhibition of catecholamine-uptake by naturally-occurring tetrahydroisoquino- lines and its possible relevance to both L’-DOPA chemotherapy in Parkinsonism and to phenylketonuria. Neurosci. Abst., 4, 428.
LOO, Y.H., 1967, Characterization of a new phenylalanine metabolite in phenylketonuria, J. Neurochem., 14, 813–821
LOO, Y.H., 1974, Serotonin deficiency in experimental hyperphenylalaninemia, J. Neurochem., 23, 139–147.
LOO, Y.H, and MACK, K., 1972, Effect of hyperphenylalaninemia on vitamin B5 metabolism in developing rat brain, J. Neurochem., 19, 2385–2394.
LOO, Y.H. and WHITTAKER, V.P., 1967, Pyridoxal kinase in brain and its inhibition by pyridoxylidene-3-phenylethylamine, J. Neurochem., 14, 997–1011.
MARKLEY, H.G. and MEZEY, E., 1978, Induction of alcohol withdrawal symptoms by nalorphine in chronic alcoholic patients, Int. J. Addict., 13, 395–402.
MEYERSON, L.R., GEORGE, B., ABEL, M., PHILIPS, H., DAVIS, V.E, and CLEMENT-CORMIER, Y.C., 1978A, Characterization of striatal 3H-apomorphine and 3H-spiroperidol binding and dopamine- sensitive adenylate cyclase activity utilizing protoberberine alkaloids. Neurosci, Abst., 4, 516.
MEYERSON, L.R., McMURTREY, K.D., and DAVIS, V.E., 1978B, Isoquinoline alkaloids: Inhibitory actions on cation-dependent ATP- phosphohydrolases. Neurochem. Res., 3, 239–257.
NIJM, W.P., BORGE, G.F., ORIGITANO, T., TEAS, G., GOLDFARB, C. and COLLINS, M.A., 1978, Lack of evidence for sustained blood acetaldehyde concentrations during alcohol detoxification. Res. Comm. Chem. Path. Pharmacol., 20, 178–190.
NIJM, W.P., RIGGIN, R., TEAS, G., KISSINGER, P.T., BORGE, G., and COLLINS, M.A., 1977, Urinary dopamine-related tetrahydroiso- quinolines: Studies of alcoholics and non-alcoholics. Fedn. Proc., 36, 334.
RAHWAN, R., 1975, Toxic effects of ethanol. Possible role of acetaldehyde, tetrahydroisoquinolines and tetrahydro-β-carbolines, Toxicol. Appl. Pharmacol. 34, 3–27.
RIGGIN, R.M. and KISSINGER, P.T., 1977, Determination of tetrahydroisoquinoline alkaloids in biological materials with high performance liquid chromatography. Anal. Chem., 49, 530–533.
ROBBINS, J.H., 1968, Possible alkaloid formation in alcoholism and other diseases. Clin. Res., 16, 554.
SANDLER, M., 1973, The DOPA effect: Possible significance of transamination and tetrahydroisoquinoline formation. Adv. Neurol. 2, 255–264.
SANDLER, M., CARTER, S.B., HUNTER, K.R., and STERN, G.M., 1973, Tetrahydroisoquinoline alkaloids: in vivo metabolites of L-DOPA in man. Nature, 241, 439–443.
SHOEMAKER, D.W., CUMMINS, J.T., and BIDDER, T.G., 1978, Beta- carbolines in rat arcuate nucleus, Neurosci., 3, 233–239.
SOURKES, T., 1969, On the mode of action of L-DOPA in Parkinson’s disease. Biochem. Med., 3, 321–325.
SMITH, A.A., 1975, Interaction of biogenic amines with ethanol, in Biochem. Pharmacol, of Ethanol (Ed. E. Majchrowicz), Plenum Press, N.Y., 265–275.
STEVENS, V.J., ROUGER, C., MONNIER, V., and CERAMI, A., 1978, Diabetic cataract formation: Potential role of lens crystallins, Proc. Nat. Acad. Sci. USA, 75, 2915–2922.
STEVENS, V.J., VLASSARA, H., ABATI, A., and CERAMI, A., 1977, Non- enzymatic glycosylation of hemoglobin, J. Biol. Chem., 252, 2998–3002.
TATTERSALL, R.B., PYKE, D.A., RANNEY, H., and BRUCKHEIMER, S.M., 1975, Hemoglobin components in diabetes mellitus. Studies in identical twins, N. Eng. J. Med., 293, 1171–1173.
WILLIAMSON, B. and CONIGLIO, J.G., 1971, The effects of pyridoxine deficiency and of caloric restriction on lipids in the developing rat brain, J. Neurochem., 18, 267–276.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Plenum Press, New York
About this chapter
Cite this chapter
Collins, M.A. (1980). Neuroamine Condensations in Human Subjects. In: Begleiter, H. (eds) Biological Effects of Alcohol. Advances in Experimental Medicine and Biology, vol 126. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3632-7_9
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3632-7_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3634-1
Online ISBN: 978-1-4684-3632-7
eBook Packages: Springer Book Archive